ConductScience.org, home
Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
API referenceFor AI assistants

Trial · NCT00975819

Adverse events26

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 26

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherBlood Bone MarrowBlood and lymphatic system disordersAll Grade 2 and Higher Adverse Events Attributable to Sirolimus5615
seriousPain- Abdomen- NOSGeneral disordersAll Grade 2 and Higher Adverse Events Attributable to Sirolimus3614
seriousAnemiaBlood and lymphatic system disordersAll Grade 2 and Higher Adverse Events Attributable to Sirolimus1611
seriousPlateletsBlood and lymphatic system disordersAll Grade 2 and Higher Adverse Events Attributable to Sirolimus1611
seriousLymphedemaBlood and lymphatic system disordersAll Grade 2 and Higher Adverse Events Attributable to Sirolimus1611
seriousNeutropeniaBlood and lymphatic system disordersAll Grade 2 and Higher Adverse Events Attributable to Sirolimus1611
seriousAppendixGastrointestinal disordersAll Grade 2 and Higher Adverse Events Attributable to Sirolimus1611
seriousColitisGastrointestinal disordersAll Grade 2 and Higher Adverse Events Attributable to Sirolimus1611
seriousDiarrheaGastrointestinal disordersAll Grade 2 and Higher Adverse Events Attributable to Sirolimus1611
seriousVomitingGastrointestinal disordersAll Grade 2 and Higher Adverse Events Attributable to Sirolimus1611
seriousHypertensionCardiac disordersAll Grade 2 and Higher Adverse Events Attributable to Sirolimus1611
seriousCellulitisInfections and infestationsAll Grade 2 and Higher Adverse Events Attributable to Sirolimus86114
seriousBacteremiaInfections and infestationsAll Grade 2 and Higher Adverse Events Attributable to Sirolimus1611
seriousSepsisInfections and infestationsAll Grade 2 and Higher Adverse Events Attributable to Sirolimus1611
seriousUrinary Tract InfectionInfections and infestationsAll Grade 2 and Higher Adverse Events Attributable to Sirolimus2612
seriousInfection- ColonInfections and infestationsAll Grade 2 and Higher Adverse Events Attributable to Sirolimus1611
seriousCVC port infectionInfections and infestationsAll Grade 2 and Higher Adverse Events Attributable to Sirolimus2612
seriousAirway/ lungInfections and infestationsAll Grade 2 and Higher Adverse Events Attributable to Sirolimus3614
seriousImmunodeficencyInfections and infestationsAll Grade 2 and Higher Adverse Events Attributable to Sirolimus1611
seriousPhlebitisInfections and infestationsAll Grade 2 and Higher Adverse Events Attributable to Sirolimus1611

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00975819/events

API referenceFor AI assistants